NHS poised to test a new longevity drug.

The NHS is preparing to test an experimental anti‑ageing drug developed by British start‑up LinkGevity, and the company has begun talks with officials about starting clinical trials.

The NHS is preparing to test an experimental anti‑ageing drug developed by the British start‑up LinkGevity. The company has described the medicine as a "Swiss army knife of drugs." Officials and the company have begun talks about initiating clinical testing. Reporting says the drug is intended to boost lifespans and treat debilitating diseases. Key facts: - The NHS is reported as preparing to test an experimental anti‑ageing drug. - LinkGevity developed the medicine and has described it as versatile. - The company has begun discussions with officials about starting clinical trials. - The drug is reported as aimed at boosting lifespans and addressing debilitating conditions. - Specific trial timing, phases, and regulatory details are not stated in the report. Summary: If the talks lead to formal trials, the drug could influence research on ageing and related diseases. The next procedural step is the progression of discussions toward clinical testing, with detailed plans and timing undetermined at this time.